Patrick Soon-Shiong Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 8

  • Portfolio
  • 2

  • Exits
  • 4

Exits

Patrick Soon-Shiong General Information

Description

Mr. Patrick Soon-Shiong is the Founder and serves as Chief Executive Officer and chairman of the Board at NantHealth. He served as a Board Member at Etubics and Sienza Energy. He serves as Chief Executive Officer, Board Member and Managing Director at NantBioscience. He also served as Interim Chief Executive Officer at Verity Health System. He is the Founder and serves as Chief Executive Officer and Board Member at NantOmics. He served as a Board Member at Keyssa. He has served as Chief Executive Officer and Chairman of our Board of Directors since NantHealth's founding in July 2010. A physician, surgeon and scientist, he has pioneered novel therapies for both diabetes and cancer, published more than 100 scientific papers, and has received over 95 patents on groundbreaking advancements spanning a myriad of fields. He served as Chairman at Altor BioScience. He is a Co-Founder and serves as Chairman at Tensorcom. He is an internationally recognized surgeon, scientist, inventor, and philanthropist with over 500 patents issued worldwide and the author of more than 100 peer-reviewed scientific publications. He serves as Executive Chairman & Global Chief Scientific and Medical Officer of ImmunityBio, a company he founded in 2014. He also serves as Chairman and the Chief Executive Officer of Nant Health (NASDAQ: NH), a transformational healthcare company converging biomolecular medicine and bioinformatics with deep learning AI. He is also the Owner and Executive Chairman of the Los Angeles Times and The San Diego Union-Tribune. He serves as Chairman of the Chan Soon-Shiong Family Foundation and of the Chan Soon-Shiong Institute of Molecular Medicine. Since the 1990s He founded and led global pharmaceutical companies, American Pharmaceutical Partners and Abraxis BioScience, the latter of which is where he developed Abraxane, the first protein nanoparticle drug for breast, lung, and pancreatic cancer. The drug has achieved blockbuster status with annual sales exceeding a billion dollars and has now been acquired by Bristol Myers Squib. His contribution to the advancement in cancer treatment has been honored by the Smithsonian National Museum of American History where Abraxane is now permanently housed, by the Friends of the National Library of Medicine Science with the Distinguished Medical Science award and by the Vatican with the Pontifical Key Visionary Award.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • Los Angeles, CA
  • United States

Patrick Soon-Shiong Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sienza Energy 17-Feb-2022 Later Stage VC 0000 Electrical Equipment Generating Revenue 0000000 0000-000000 00
X vs X Sports 18-Oct-2019 00000 (00000 000 Information Services (B2C) Generating Revenue 0000000 0000-000000 00
Zoom Video Communications 04-Feb-2015 00000 00000 0000 Communication Software Profitable 0000000 0000-000000 00
NantKwest 26-Dec-2014 00000 00000 0000 Drug Discovery Generating Revenue 0000000 0000-000000 00
NantMobile 30-Oct-2014 00000 00000 0000 Business/Productivity Software Generating Revenue 0000000 0000-000000 00
Zoom Video Communications 24-Sep-2013 00000 00000 00.000 Communication Software Profitable 0000000 0000-000000 00
Prizeo US 06-Jun-2013 Seed Round 00.00 Financial Software Generating Revenue 0000000 0000-000000 00
Zoom Video Communications 28-Jan-2013 Early Stage VC 000 Communication Software Profitable 0000000 0000-000000 00

Patrick Soon-Shiong Exits (4)

Company Name Exit Date Exit Type Exit Size
NantMobile 01-Nov-2022 Secondary Transaction - Private
Zoom Video Communications 18-Apr-2019 000 00000
NantKwest 28-Jul-2015 IPO 00000
Prizeo US 23-Jun-2015 Merger/Acquisition

Patrick Soon-Shiong Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Patrick Soon-Shiong Team (1)

Name Title Deals Funds Boards Office
Patrick Soon-Shiong MD Angel Investor 00 00 Los Angeles, CA

Patrick Soon-Shiong FAQs

  • Who is Patrick Soon-Shiong?

    Patrick Soon-Shiong is an angel Investor who has made 8 investments.

  • What kind of investor is Patrick Soon-Shiong?

    Patrick Soon-Shiong is an angel investor.

  • What does Patrick Soon-Shiong do?

    As an angel investor, Patrick Soon-Shiong invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Patrick Soon-Shiong hold?

    Patrick Soon-Shiong holds 2 board seats including Sienza Energy and Personal Genomics.

  • What has Patrick Soon-Shiong invested in?

    Patrick Soon-Shiong has made numerous investments in companies like Sienza Energy, X vs X Sports, and Zoom Video Communications within the Electrical Equipment, Information Services (B2C), and Communication Software industries.

  • What has Patrick Soon-Shiong invested in recently?

    Patrick Soon-Shiong's latest investment was on 17-Feb-2022 in Sienza Energy, a company within the Electrical Equipment industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »